My Application Form Status

Check the status of your application form with Angel Broking.
Bhandari Hosiery Exports to hold board meeting
Nov 04,2016

Bhandari Hosiery Exports will hold a meeting of the Board of Directors of the Company on 12 November 2016, to consider & approve Unaudited Financial Results for the Quarter/half year ended 30 September 2016.

Powered by Capital Market - Live News

Jagsonpal Finance & Leasing to hold board meeting
Nov 04,2016

Jagsonpal Finance & Leasing will hold a meeting of the Board of Directors of the Company on 12 November 2016, to approve the Un-Audited Financial Results for the Second Quarter (Q2) and Half Year ended on 30 September 2016.

Powered by Capital Market - Live News

Anna Infrastructures to hold board meeting
Nov 04,2016

Anna Infrastructures will hold a meeting of the Board of Directors of the Company on 12 November 2016, to approve the Un-Audited Financial Results for the Quarter ended on 30 September 2016.

Powered by Capital Market - Live News

Soni Medicare to hold board meeting
Nov 04,2016

Soni Medicare will hold a meeting of the Board of Directors of the Company on 11 November 2016, to consider, approve and take on record the Standalone Unaudited Financial Results of the company for the second quarter ended on 30 September 2016 along with the limited review report of the auditors.

Powered by Capital Market - Live News

NRB Bearings to hold board meeting
Nov 04,2016

NRB Bearings will hold a meeting of the Board of Directors of the Company on 14 November 2016, to consider inter-alia adoption of unaudited financial results for the quarter ended 30 September 2016.

Powered by Capital Market - Live News

IVP to hold board meeting
Nov 04,2016

IVP will hold a meeting of the Board of Directors of the Company on 14 November 2016.

Powered by Capital Market - Live News

Arihant Capital Markets to hold board meeting
Nov 04,2016

Arihant Capital Markets will hold a meeting of the Board of Directors of the Company on 14 November 2016, to approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the 2nd quarter / Half year ended on 30 September 2016.

Powered by Capital Market - Live News

Oriental Bank of Commerce to hold board meeting
Nov 04,2016

Oriental Bank of Commerce will hold a meeting of the Board of Directors of the Company on 9 November 2016, to approve the reviewed Financial Results of the Bank for the quarter and half year ended

Powered by Capital Market - Live News

IMP Powers to hold board meeting
Nov 04,2016

IMP Powers will hold a meeting of the Board of Directors of the Company on 10 November 2016, to approve the Un-Audited Financial Results (consolidated & standalone) for the quarter ended 30 September 2016.

Powered by Capital Market - Live News

Olympia Capitals to hold board meeting
Nov 04,2016

Olympia Capitals will hold a meeting of the Board of Directors of the Company on 14 November 2016, to approve the Unaudited Financial Results of the Company for the Quarter and six months ended on 30 September 2016.

Powered by Capital Market - Live News

Berger Paints gains after good Q2 results
Nov 04,2016

The result was announced after market hours yesterday, 3 November 2016.

Meanwhile, the S&P BSE Sensex was down 19.64 points or 0.07% at 27,410.64.

On BSE, so far 78,000 shares were traded in the counter as against average daily volume of 52,000 shares in the past two weeks. The stock hit a high of Rs 270 and a low of Rs 262 so far during the day. The stock had hit a record high of Rs 276.80 on 12 September 2016. The stock had hit a 52-week low of Rs 152.86 on 14 December 2015.

The large-cap company has equity capital of Rs 97.10 crore. Face value per share is Rs 1.

The bottom line in Q2 September 2016 was boosted by Rs 44.20 crore on account of profit from sale of business to Berger Nippon Paint Automotive Coatings, a joint venture company in which Berger Paints India holds 49% of the paid-up capital.

Berger Paints India manufactures and markets a range of decorative and industrial paint products and has operations throughout India.

Powered by Capital Market - Live News

Ganon Trading & Finance Company to hold board meeting
Nov 04,2016

Ganon Trading & Finance Company will hold a meeting of the Board of Directors of the Company on 14 November 2016, to approve the unaudited financial result of the company for the Quarter ended 30 September 2016.

Powered by Capital Market - Live News

Ace Software Exports to hold board meeting
Nov 04,2016

Ace Software Exports will hold a meeting of the Board of Directors of the Company on 12 November 2016, to consider and approve un-audited results of the company for the quarter/half year ended on 30 September 2016 and to consider and approve other agenda.

Powered by Capital Market - Live News

Mylan and Biocons provides update on its regulatory submission for Insulin Glargine
Nov 04,2016

Mylan N.V. and Biocon announced that the European Medicines Agency (EMA) has accepted for review Mylans Marketing Authorization Application (MAA) for insulin glargine, a long-acting insulinanalog used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar.

Mylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients, who are often facing significant expense to manage their disease. This filing includes analytical, functional and pre-clinical data, as well as results

Powered by Capital Market - Live News

Mylan and Biocons provides update on its regulatory submission for Insulin Glargine
Nov 04,2016

Mylan N.V. and Biocon announced that the European Medicines Agency (EMA) has accepted for review Mylans Marketing Authorization Application (MAA) for insulin glargine, a long-acting insulinanalog used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar.

Mylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients, who are often facing significant expense to manage their disease. This filing includes analytical, functional and pre-clinical data, as well as results

Powered by Capital Market - Live News